All News


 

2018

May

Media Release / May 25, 2018

Important Announcement: Avara intends to acquire our plant and development center in Boucherville.

Read More

April

Media Release / Apr 19, 2018

Four Canadian provinces add Erelzi™ (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases

Read More

March

Media Release / Mar 07, 2018

Sandoz Canada launches two new generic therapies for hypertension

Read More

February

Media Release / Feb 06, 2018

Sandoz Canada amongst Top Employers in Montreal

Read More
Media Release / Feb 05, 2018

Quebec adds Erelzi™ (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases

Read More

January

Media Release / Jan 09, 2018

Ontario has added ErelziTM (etanercept) to public drug plan for the treatment of multiple inflammatory diseases

Read More
2017

November

Media Release / Nov 16, 2017

British Columbia and Prince Edward Island become the first provinces to add ErelziTM (etanercept) to public drug plans for the treatment of multiple inflammatory diseases

Read More

October

Media Release / Oct 27, 2017

Sandoz proposed biosimilar pegfilgrastim accepted by EMA for regulatory review

Read More

August

Media Release / Aug 20, 2017

Sandoz ErelziTM (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases

Read More
Media Release / Aug 20, 2017

ErelziTM (etanercept), by Sandoz, is now available for patients in Canada for the treatment of multiple inflammatory diseases

Read More

Pages